Neighborhood pharmacies struggle to stay open due to PBM restrictions
As COVID-19 cases skyrocket in Florida, we’ve talked a lot about what doctors’ offices are doing, but what about pharmacies?
Read moreLatest News
Trump will sign three executive orders on lowering drug prices: chief of staff
President Donald Trump will sign three executive orders on lowering prescription drug prices, White House Chief of Staff Mark Meadows
Read moreHRSA Says its 340B Contract Pharmacy Guidance Is Not Legally Enforceable
In what some perceive as a break with a position dating back to 1996, the U.S. Health Resources and Services
Read moreCMS’s Proposed Medicaid Best Price Loophole for Value-Based Purchasing Of Drugs
For three decades, US pharmaceutical companies have agreed to sell their products to Medicaid programs at the lowest price available
Read moreWalgreens strikes deal with primary-care company to open doctor offices in hundreds of drugstores
Walgreens Boots Alliance will soon have doctor offices inside of hundreds of its U.S. drugstores. The pharmacy chain said Wednesday it
Read moreMany hospitals aren’t pausing procedures as coronavirus cases rise
Hospitals in coronavirus hotspots are not scaling back their elective procedures, even as their intensive-care units are filling up with
Read moreNorthShore to acquire one of the Chicago area’s few remaining independent hospitals
NorthShore University HealthSystem plans to acquire Northwest Community Healthcare — which runs one of the few remaining independent hospitals in
Read moreStartup PBM Capital Rx, Walmart partner to shed light on specialty, mail-order drug prices
Startup pharmacy benefit manager Capital Rx is teaming up with Walmart to bring greater transparency to specialty and mail-order prescriptions.
Read moreNew York City hospital, oncology practice to build cancer center
The Brooklyn Hospital Center in New York City is partnering with New York Cancer & Blood Specialists to build a
Read moreWith a clinical hold, off-the-shelf CAR-T hits a new safety concern
The Food and Drug Administration has placed a clinical hold on one of Cellectis’s off-the-shelf CAR-T trials after one patient
Read more